A B S T R A C T Bloom's syndrome is a rare autosomal recessive disorder, first characterized by growth retardation and a sun-sensitive facial telangiectasia and more recently demonstrated to have increased chromosome instability, a predisposition to malignancy, and increased susceptibility to infection. The present report concerns the immune function of Bloom's syndrome lymphocytes in vitro. Four affected homozygotes and five heterozygotes were studied. All abnormal serum concentration of at least one class of inmmunoglobulin was present in three out of four homozygotes. Affected hoomozygotes were shown capable of both aI humoral and a cellular response after alntigenic challenge, the responses in gelleral being weak but detectable.
Blood lymphocytes from Bloom's syndrome individuals were cultured in the presence of pokeweed mitogen. The cells had an impaired proliferative response and synthesized less immunoglobulin at the end of 5 days than did normal controls. In contrast, they had a normal proliferative response to phytohemagglutinin except at highest concentrations of the mitogen. In the mixed lymphocyte culture, Bloom's syndrome lymphocytes proved to be poor responder cells but normal stimulator cells. Lymphocytes from the heterozygotes produced normal responses in these three systems. Disturbed immunity appears to be one of several major consequences of homozygosity for the Bloom's syndrome gene. Although the explanation for this pleio- 
METHODS
Affected homiozygotes, letcrozygotes, and controls. Four unrelated individuals with Bloom's syndrome were studied, one female and three males ranging in age from 2 to 23 yr. They are identified, as in reference 1, as 3 (HoCo), 32 (MiKo), 47 (ArSmi), and 50 (JeBl). The diagnosis was made on the basis of the classical clinical features and the finding of increased chromosome breakage in dermal fibroblasts, blood lymphocytes, or both. Five parents of three of the affected, ranging in age from 21 to 42 yr, were included in the study and will be referred to as "heterozygotes." 12 normal persons ranging in age from 2 to 47 yr served as controls. All subjects were clinically well and were not receiving medication at the time of the study. Hz vs. NI, nonsignificant. P < 0.0025 P < 0.0005 P < 0.0025 P <0.01 P < 0.0025 P < 0.025 tails of the method will be described elsewhere (T. H.
Hiitteroth and S. D. Litwin, manuscript in preparation).
Combined assay for membrane Ig-bearing and sheep red cell rosette-forming lymphocytes. This was performed as described previously (6) . Group comparisons, nonsignificant. Lymphocyte stimulation by PHA. The proliferative response to different concentrations of PHA was studied after 78-and 126-h culture periods (Fig. 2) . After 78 h the maximum proliferation did not differ between cultures of lymphocytes from individuals with Bloom's syndrome, heterozygotes, and controls except at the highest concentration of 2 /Lg/0.2 ml of PHA, at which Bloom's syndrome individuals showed a lower response than controls (Fig. 2A) . After 126 h the proliferative response did not differ between cultures from persons with Bloom's syndrome, heterozygotes, and controls (Fig. 2B) at aiy concentration.
The effect of the source of the serum used in the culture medium on proliferation of lymphocytes from Bloom's syndrome and control individuals was analyzed in two experiments using optimal concentrations of PWM (5 X 10' dilution) and PHA (0.2 /tg). No serum was compared to homologous serum from normal persons. MLC experiments. The ability of lymphocytes from persons with Bloom's syndrome to react to allogeneic cells was investigated in the one-way MLC (Table I) . In each experiment, one person with Bloom's syndrome was studied together with one or two heterozygotes and three normal controls. To obtain suitable numbers for statistical analysis, the ['H]thymidine-incorporation data of identical responder-stimulator combinations from all experiments were pooled and compared to other responder-stimulator combinations. The results demonstrated that lymphocytes from individuals with Bloom's syndrome responded less vigorously to normal stimulator lymphocytes than did normal responder lymphocytes to normal stimulator lymphocytes. The differences between the following groups were statistically significant (see Table I Ig synthesis and secretion after PWM stimulation. PWM is known to induce Ig synthesis and secretion in lymphocytes from normal individuals (9) . Here, lymphocyte cultures from the three persons with Bloom's syndrome tested synthesized less total cellular protein and had a lower percent Ig/TCA than control cultures (Table II). Parallel results were obtained from the medium in which the cells had been cultured. The DISCUSSION Previous clinical observations of repeated bacterial infections in the majority of Bloom's syndrome patients and reports from several laboratories (10, 11) of decreased concentrations of serum Igs both had suggested the existence of an impairment of immune function in vivo in this rare genetic disorder. All four of the affected individuals in the present report have had repeated infections requiring antibiotics, three had definite decreases in serum Ig, one possibly had a low IgA. As adjuncts to our investigation of the immune response in vitro of Bloom's syndrome lymphocytes, the affected individuals were challenged with a panel of antigens, and it was shown that delayed hypersensitivity could be elicited and that a humoral immune response followed tetanus and influenza vaccination. It should be noted, however, that although the responses were present they were generally weak, and the limited data cannot rule out partial impairment.
In the present study, we have shown the following abnormalities in vitro in the blood lymphocytes of individuals with Bloom's syndrome: (a) In short-term culture with PWM there was an impaired proliferative response as measured by incorporation of radiolabeled thymidine and a decreased synthesis of Ig as determined by an immunoprecipitation assay. (b) In the one-way MLC, Bloom's syndrome lymphocytes are poor responder cells but normal stimulator cells.
The pattern of immune dysfunction encountered in Bloom's syndrome differs from that described for other immunodeficiencies and raises questions as to the nature of the inherited defect. The disturbances demonstrated could be on the basis of an abnormal B-or T-lymphocyte function, of abnormal processing or recognition of antigen, or of abnormality in some general activity such as cellular proliferation, an activity not restricted just to lymphocytes and the immune system.
Dysfunction of B lymphocytes is suggested by the poor responses made by the blood lymphocytes cultured with PWM. PWM has been found to stimulate predominantly B lymphocytes (12, 13) , although a recent investigation has shown that both T and B lymphocytes will undergo mitosis when PWM is added to cell cultures in which both types of lymphocytes are present (14) . When human lymphocytes are cultured in the presence of PWM, plasmacytoid cells develop (15) and cellular synthesis of Ig occurs (9 (17) .
A disparity exists between the findings on the one hand of a normal response to PHA (in other than the highest dosage), which suggests adequate T-lymphocyte function, and on the other hand of an impaired response in the MLC, which indicates defective T-lymphocyte function (18) . The response in the MLC may be a more sensitive indicator of T-lymphocyte function than the PHA response, or the response in the MLC and that to PHA may assay different subpopulations of T lymphocytes. A similar aberration has been described in the Wiskott-Aldrich syndrome, in which a normal response to PHA is usually found along with decreased MLC reactivity (19) . A dissociation in the opposite direction, PHA unresponsiveness and MLC responsiveness, has been described in human lymphoid cells from fetal liver (20) and in cases of combined immunodeficiency (21, 22) . In Bloom's syndrome, evidence against an abnormal distribution in the blood of various lymphocyte subpopulations was obtained, normal proportions of B and T lymphocytes being demonstrable. At the present time, the disturbed immune function in Bloom's syndrome cannot be explained in terms of the known functions of lymphocyte subpopulations.
Chromosome instability ("breakage") and a predisposition to malignancy are found in at least three recessively transmitted human disorders, Bloom's syndrome, Fanconi's anemia, and ataxia telangiectasia. Xeroderma pigmentosum probably also should be included in this group of disorders (2) . Two of these rare disorders, Bloom's syndrome and ataxia telangiectasia, and possibly xeroderma pigmentosum as well (23) , also show immunological abnormalities. Both chromosomal abnormalities and immunologic impairment have been associated with human malignancies (3, 19) . The latter, the immune deficiency, offers a direct explanation of the tendency of Bloom's syndrome individuals to develop malignancy prematurely, if the concept of immune surveillance is invoked. Support for immunologic surveillance has come from the predisposition to malignancy of persons with several forms of primary immunodeficiencies (19) . Present information indicates that the immunologic abnormalities in ataxia telangiectasia involve cell-mediated immunity, with histologic changes in the thymus gland and frequently an absence of serum IgA, IgE, or both (19) . A recent report has described defects in cellular immunity in xeroderma pigmentosum (23) . It is clear that the pattern of immunologic abnormalities reported here in Bloom's syndrome is not the same as that in either ataxia telangiectasia or xeroderma pigmentosum; also, its pattern of chromosome aberrations is of a specific type (24, 25) .
In summary, despite the above provocative findings, no common denominator is yet apparent in these various genetic disorders, and no biological links between "chromosome breakage," impaired immune responses, and cancer can be identified at present.
It would seem reasonable at this point to speculate that although the genetic defect in each of these rare disorders just mentioned differs, they may all relate to the same biologic function. There is evidence of im-paired cellular proliferation in Bloom's syndrome. Growth retardation is a major clinical feature of the disease. Tissue cultures of dermal fibroblasts require longer periods of time between subculturing than do lines from most normal persons, and the cultures tend to have a short life span (J. German, unpublished observations). DNA chain elongation during the S phase of the cell division cycle in cultured skin fibroblasts from persons with Bloom's syndrome proceeds at a slower rate than in normal fibroblasts (26) . Also, possibly related to a proliferative defect are our (T. H. Hutteroth and S. D. Litwin) unsuccessful attempts at establishing lymphoblastoid cell lines from Bloom's syndrome blood, despite a number of attempts using different culture conditions. The possibility should be considered that the immunologic abnormalities found in persons with Bloom's syndrome and other genetically determined disorders are secondary to a disturbance in cellular proliferation, with the specific pattern of immune defects dependent on the nature and severity of the proliferative defect and on the class of cells affected.
